365 related articles for article (PubMed ID: 31382521)
21. Apolipoprotein A-II modulates the binding and selective lipid uptake of reconstituted high density lipoprotein by scavenger receptor BI.
de Beer MC; Durbin DM; Cai L; Mirocha N; Jonas A; Webb NR; de Beer FC; van Der Westhuyzen DR
J Biol Chem; 2001 May; 276(19):15832-9. PubMed ID: 11279034
[TBL] [Abstract][Full Text] [Related]
22. Artificial high-density lipoprotein-mimicking nanotherapeutics for the treatment of cardiovascular diseases.
He H; Hong K; Liu L; Schwendeman A
Wiley Interdiscip Rev Nanomed Nanobiotechnol; 2021 Nov; 13(6):e1737. PubMed ID: 34263549
[TBL] [Abstract][Full Text] [Related]
23. Structure and remodeling behavior of drug-loaded high density lipoproteins and their atherosclerotic plaque targeting mechanism in foam cell model.
Zhang WL; Xiao Y; Liu JP; Wu ZM; Gu X; Xu YM; Lu H
Int J Pharm; 2011 Oct; 419(1-2):314-21. PubMed ID: 21835236
[TBL] [Abstract][Full Text] [Related]
24. Structural and Functional Changes of Reconstituted High-Density Lipoprotein (HDL) by Incorporation of α-synuclein: A Potent Antioxidant and Anti-Glycation Activity of α-synuclein and apoA-I in HDL at High Molar Ratio of α-synuclein.
Cho KH
Molecules; 2021 Dec; 26(24):. PubMed ID: 34946565
[TBL] [Abstract][Full Text] [Related]
25. HDL-Mediated Lipid Influx to Endothelial Cells Contributes to Regulating Intercellular Adhesion Molecule (ICAM)-1 Expression and eNOS Phosphorylation.
Muñoz-Vega M; Massó F; Páez A; Vargas-Alarcón G; Coral-Vázquez R; Mas-Oliva J; Carreón-Torres E; Pérez-Méndez Ó
Int J Mol Sci; 2018 Oct; 19(11):. PubMed ID: 30380707
[TBL] [Abstract][Full Text] [Related]
26. The conformation of apolipoprotein A-I in high-density lipoproteins is influenced by core lipid composition and particle size: a surface plasmon resonance study.
Curtiss LK; Bonnet DJ; Rye KA
Biochemistry; 2000 May; 39(19):5712-21. PubMed ID: 10801321
[TBL] [Abstract][Full Text] [Related]
27. Cell cholesterol efflux to reconstituted high-density lipoproteins containing the apolipoprotein A-IMilano dimer.
Calabresi L; Canavesi M; Bernini F; Franceschini G
Biochemistry; 1999 Dec; 38(49):16307-14. PubMed ID: 10587455
[TBL] [Abstract][Full Text] [Related]
28. Lipoprotein-Related and Apolipoprotein-Mediated Delivery Systems for Drug Targeting and Imaging.
Almer G; Mangge H; Zimmer A; Prassl R
Curr Med Chem; 2015; 22(31):3631-51. PubMed ID: 26180001
[TBL] [Abstract][Full Text] [Related]
29. Delivery of hydrophilic drug doxorubicin hydrochloride-targeted liver using apoAI as carrier.
Yuan Y; Wang W; Wang B; Zhu H; Zhang B; Feng M
J Drug Target; 2013 May; 21(4):367-74. PubMed ID: 23600747
[TBL] [Abstract][Full Text] [Related]
30. High-Density Lipoprotein Nanobiologics for Precision Medicine.
Mulder WJM; van Leent MMT; Lameijer M; Fisher EA; Fayad ZA; Pérez-Medina C
Acc Chem Res; 2018 Jan; 51(1):127-137. PubMed ID: 29281244
[TBL] [Abstract][Full Text] [Related]
31. A novel compound inhibits reconstituted high-density lipoprotein assembly and blocks nascent high-density lipoprotein biogenesis downstream of apolipoprotein AI binding to ATP-binding cassette transporter A1-expressing cells.
Lyssenko NN; Brubaker G; Smith BD; Smith JD
Arterioscler Thromb Vasc Biol; 2011 Nov; 31(11):2700-6. PubMed ID: 21836073
[TBL] [Abstract][Full Text] [Related]
32. Direct Measurement of the Structure of Reconstituted High-Density Lipoproteins by Cryo-EM.
Murray SC; Gillard BK; Ludtke SJ; Pownall HJ
Biophys J; 2016 Feb; 110(4):810-6. PubMed ID: 26743047
[TBL] [Abstract][Full Text] [Related]
33. Tumor targeting effects of a novel modified paclitaxel-loaded discoidal mimic high density lipoproteins.
Wang J; Jia J; Liu J; He H; Zhang W; Li Z
Drug Deliv; 2013 Nov; 20(8):356-63. PubMed ID: 24079327
[TBL] [Abstract][Full Text] [Related]
34. Apolipoprotein A-II inhibits high density lipoprotein remodeling and lipid-poor apolipoprotein A-I formation.
Rye KA; Wee K; Curtiss LK; Bonnet DJ; Barter PJ
J Biol Chem; 2003 Jun; 278(25):22530-6. PubMed ID: 12690114
[TBL] [Abstract][Full Text] [Related]
35. Ability of reconstituted high density lipoproteins to inhibit cytokine-induced expression of vascular cell adhesion molecule-1 in human umbilical vein endothelial cells.
Baker PW; Rye KA; Gamble JR; Vadas MA; Barter PJ
J Lipid Res; 1999 Feb; 40(2):345-53. PubMed ID: 9925665
[TBL] [Abstract][Full Text] [Related]
36. The number of amphipathic alpha-helical segments of apolipoproteins A-I, E, and A-IV determines the size and functional properties of their reconstituted lipoprotein particles.
Jonas A; Steinmetz A; Churgay L
J Biol Chem; 1993 Jan; 268(3):1596-602. PubMed ID: 8420935
[TBL] [Abstract][Full Text] [Related]
37. Reconstituted Discoidal High-Density Lipoproteins: Bioinspired Nanodiscs with Many Unexpected Applications.
Tsujita M; Wolska A; Gutmann DAP; Remaley AT
Curr Atheroscler Rep; 2018 Nov; 20(12):59. PubMed ID: 30397748
[TBL] [Abstract][Full Text] [Related]
38. Cholesterol mobilization by free and lipid-bound apoAI(Milano) and apoAI(Milano)-apoAII heterodimers.
Wang WQ; Moses AS; Francis GA
Biochemistry; 2001 Mar; 40(12):3666-73. PubMed ID: 11297434
[TBL] [Abstract][Full Text] [Related]
39. Exploring the therapeutic potential of the bioinspired reconstituted high density lipoprotein nanostructures.
Gupta A; Sharma R; Kuche K; Jain S
Int J Pharm; 2021 Mar; 596():120272. PubMed ID: 33486038
[TBL] [Abstract][Full Text] [Related]
40. Displacement of apo A-I from HDL by apo A-II or its C-terminal helix promotes the formation of pre-beta1 migrating particles and decreases LCAT activation.
Labeur C; Lambert G; Van Cauteren T; Duverger N; Vanloo B; Chambaz J; Vandekerckhove J; Castro G; Rosseneu M
Atherosclerosis; 1998 Aug; 139(2):351-62. PubMed ID: 9712342
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
